or Try an Advanced Search...

    Stage Pharmaceutical Stocks List

    Symbol Grade Name % Change
    HRMY B Harmony Biosciences Holdings, Inc. -1.90
    CRMD B CorMedix Inc 0.25
    RPHM D Reneo Pharmaceuticals, Inc. 0.59
    CRNX D Crinetics Pharmaceuticals, Inc. 1.60
    RVPH D Reviva Pharmaceuticals Holdings, Inc. -1.39
    MBRX D Moleculin Biotech, Inc. -1.76
    SVRA D Savara, Inc. -5.90
    CASI D CASI Pharmaceuticals, Inc. -8.93
    PSTV F Plus Therapeutics, Inc. -10.27
    KALV F KalVista Pharmaceuticals, Inc. -1.64
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Cancer Disease Medicine Blastoma Chloroarenes Clinical Medicine Drugs Glioblastoma Multiple Myeloma Organ Systems Ovarian Cancer Transcription Factors Acromegaly Acute Myeloid Leukemia Advanced Solid Tumors Angioedema Antineoplastic Drugs Autoimmune Disease Biotechnology

    Related ETFs - A few ETFs which own one or more of the above listed Stage Pharmaceutical stocks.

    Symbol Grade Name Weight
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.79
    CNCR D Loncar Cancer Immunotherapy ETF 0.73
    YOLO F AdvisorShares Pure Cannabis ETF 0.4
    IWC C iShares Microcap ETF 0.02
    VTI B Vanguard Total Stock Market ETF 0.0
    View all Stage Pharmaceutical ETFs...
    Compare ETFs
    Compare CNCR to VTI Compare LABD to CNCR Compare LABD to VTI

        Stage Pharmaceutical Stocks Recent News

        Date Stock Title
        Oct 1 HRMY HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY
        Oct 1 SVRA Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting
        Sep 30 KALV KalVista Announces the Submission of Additional Marketing Authorization Applications for Sebetralstat for the Oral On-Demand Treatment of Hereditary Angioedema
        Sep 29 HRMY Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?
        Sep 27 SVRA Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
        Sep 27 HRMY Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?
        Sep 26 CRNX Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
        Sep 26 CASI CASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past week
        Sep 26 RVPH Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
        Sep 26 HRMY HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024
        Sep 26 KALV KalVista Pharmaceuticals Announces Nine Abstracts Accepted for Presentation at the HAEi Global Angioedema Forum (GAF)
        Sep 25 HRMY Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
        Sep 25 CRMD CorMedix Inc. (NASDAQ:CRMD): When Will It Breakeven?
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Medicine Cancer Disease Oncology Pharmaceutical Aging Associated Diseases Antibody Drug Conjugate Blastoma Brain Tumor Cannabinoid Cannabis Central Nervous System Tumors Chemotherapy Clinical Medicine Dementia Dermatology Dog Epidermolysis Bullosa Evofosfamide Genodermatoses
        Stage Pharmaceutical

        Stage Pharmaceutical is a biopharmaceutical company focused on developing innovative treatments for rare and neglected diseases. The company is developing a portfolio of novel therapies for rare and neglected diseases, including rare genetic disorders, rare cancers, and rare infectious diseases. Stage Pharmaceutical is committed to developing treatments that are safe, effective, and affordable for patients.

        Browse All Tags